Ranbaxy taking drugs to US, UK for trials

By SiliconIndia   |   Thursday, 25 September 2003, 07:00 Hrs
Printer Print Email Email
NEW DELHI: IndiaÂ’s largest exporter of drugs, Ranbaxy Laboratories, on Wednesday said it will take some more of its products under development for trials to the United States, Britain and Canada.

Ranbaxy, which recently tied up with Schwarz Pharma AG for development of its new drug RBX 2258 for the treatment of benign prostatic hyperplasic, said it is considering taking some drugs under development for trials in the US and the UK.

“We have five to six products under various phases of clinical trials and we will take some of them to the US and UK,” Ranbaxy CEO and managing director D S Brar said.





SPOTLIGHT
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..